Literature DB >> 18267278

Oscillatory activity in the basal ganglia.

Alexandre Eusebio1, Peter Brown.   

Abstract

The exact mechanisms underlying the dysfunction of the basal ganglia (BG) that leads to movement disorders such as Parkinson's disease (PD) and dystonia still remain unclear. The classic model, based on two distinct pathways and described nearly 20 years ago by Albin and Delong, fails to explain why lesion or stimulation of the globus pallidus interna improves dyskinesias and why lesion or stimulation of the thalamus does not cause prominent bradykinesia. These paradoxes, initially highlighted out by Marsden and Obeso, led to the proposition that the pattern of neuronal discharge determines pathological function. Accordingly, over the past decade, attention has switched from considerations of discharge rate to the characterisation of synchronised activity within BG networks. Here we would like to briefly review current knowledge about synchronised oscillatory activity in the BG and focus on its relationship to abnormal motor function. In particular, we hypothesise that the frequency of synchronisation helps determine the nature of any motor deficit, perhaps as a consequence of the different tuning properties of basal ganglia-cortical sub-circuits.

Entities:  

Mesh:

Year:  2007        PMID: 18267278     DOI: 10.1016/S1353-8020(08)70044-0

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  17 in total

1.  Oscillatory Activity in Basal Ganglia and Motor Cortex in an Awake Behaving Rodent Model of Parkinson's Disease.

Authors:  Claire Delaville; Ana V Cruz; Alex J McCoy; Elena Brazhnik; Irene Avila; Nikolay Novikov; Judith R Walters
Journal:  Basal Ganglia       Date:  2014-04-01

2.  Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease.

Authors:  Sang Jin Kim; Kaviraja Udupa; Zhen Ni; Elena Moro; Carolyn Gunraj; Filomena Mazzella; Andres M Lozano; Mojgan Hodaie; Anthony E Lang; Robert Chen
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

3.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

4.  Pallidal deep brain stimulation modulates excessive cortical high β phase amplitude coupling in Parkinson disease.

Authors:  Mahsa Malekmohammadi; Nicholas AuYong; Joni Ricks-Oddie; Yvette Bordelon; Nader Pouratian
Journal:  Brain Stimul       Date:  2018-01-31       Impact factor: 8.955

5.  Pallidal low β-low γ phase-amplitude coupling inversely correlates with Parkinson disease symptoms.

Authors:  Christos Tsiokos; Mahsa Malekmohammadi; Nicholas AuYong; Nader Pouratian
Journal:  Clin Neurophysiol       Date:  2017-09-05       Impact factor: 3.708

6.  Understanding Parkinson's disease and deep brain stimulation: Role of monkey models.

Authors:  Jerrold L Vitek; Luke A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

7.  Subthalamic nucleus activity in the awake hemiparkinsonian rat: relationships with motor and cognitive networks.

Authors:  Claire Delaville; Alex J McCoy; Colin M Gerber; Ana V Cruz; Judith R Walters
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

8.  Pallidal stimulation in Parkinson disease differentially modulates local and network β activity.

Authors:  Mahsa Malekmohammadi; Yalda Shahriari; Nicholas AuYong; Andrew O'Keeffe; Yvette Bordelon; Xiao Hu; Nader Pouratian
Journal:  J Neural Eng       Date:  2018-07-04       Impact factor: 5.379

9.  Origins and suppression of oscillations in a computational model of Parkinson's disease.

Authors:  Abbey B Holt; Theoden I Netoff
Journal:  J Comput Neurosci       Date:  2014-08-07       Impact factor: 1.621

10.  Effects of dopamine depletion on LFP oscillations in striatum are task- and learning-dependent and selectively reversed by L-DOPA.

Authors:  Nuné Lemaire; Ledia F Hernandez; Dan Hu; Yasuo Kubota; Mark W Howe; Ann M Graybiel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.